Consulta Ltd

Holdings History for HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA)

Symbol: HCA on NYSE
Investment type: Equity / Common Stock, par value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-3.6%	$0	0	-150,000	-100%	$497.54	Q4 2025
30 Sep 2025	3.6%	-2.4%	$63,930,000	150,000	-100,000	-40%	$426.20	Q3 2025
30 Jun 2025	6.1%	-8.6%	$95,775,000	250,000	-350,000	-58%	$383.10	Q2 2025
31 Mar 2025	14%	+1.2%	$207,330,000	600,000	+50,000		$345.55	Q1 2025
31 Dec 2024	11%	+5.4%	$165,082,500	550,000	+275,000	+100%	$300.15	Q4 2024
30 Sep 2024	6.9%	-1.3%	$111,768,250	275,000	-50,000	-15%	$406.43	Q3 2024
30 Jun 2024	7.1%	-1.6%	$104,416,000	325,000	-75,000	-19%	$321.28	Q2 2024
31 Mar 2024	8.6%	-2.1%	$133,412,000	400,000	-100,000	-20%	$333.53	Q1 2024
31 Dec 2023	8.9%	+2.7%	$135,340,000	500,000	+150,000	+43%	$270.68	Q4 2023
30 Sep 2023	6.2%	+1.3%	$86,093,000	350,000	+75,000	+27%	$245.98	Q3 2023
30 Jun 2023	5.8%	-1.6%	$83,457,000	275,000	-75,000	-21%	$303.48	Q2 2023
31 Mar 2023	7.3%	-3.6%	$92,288,000	350,000	-175,000	-33%	$263.68	Q1 2023
31 Dec 2022	11%	-4.6%	$125,979,000	525,000	-225,000	-30%	$239.96	Q4 2022
30 Sep 2022	14%	+2.3%	$137,843,000	750,000	+125,000	+20%	$183.79	Q3 2022
30 Jun 2022	6.8%	+1.9%	$105,038,000	625,000	+175,000	+39%	$168.06	Q2 2022
31 Mar 2022	5.7%	-3.1%	$112,779,000	450,000	-250,000	-36%	$250.62	Q1 2022
31 Dec 2021	8.9%	-2.1%	$179,844,000	700,000	-165,000	-19%	$256.92	Q4 2021
30 Sep 2021	10%	-0.73%	$209,953,000	865,000	-60,000	-6.5%	$242.72	Q3 2021
30 Jun 2021	9%	-2.7%	$191,235,000	925,000	-275,000	-23%	$206.74	Q2 2021
31 Mar 2021	12%	-2.9%	$226,008,000	1,200,000	-300,000	-20%	$188.34	Q1 2021
31 Dec 2020	13%	-1.6%	$246,690,000	1,500,000	-175,000	-10%	$164.46	Q4 2020
30 Sep 2020	14%	+0.63%	$208,839,000	1,675,000	+75,000	+4.7%	$124.68	Q3 2020
30 Jun 2020	12%	+0.73%	$155,296,000	1,600,000	+100,000	+6.7%	$97.06	Q2 2020
31 Mar 2020	11%	+7.8%	$134,775,000	1,500,000	+1,050,000	+233%	$89.85	Q1 2020
31 Dec 2019	5.6%	+2.5%	$66,515,000	450,000	+200,000	+80%	$147.81	Q4 2019
30 Sep 2019	2.6%	0%	$30,105,000	250,000	0		$120.42	Q3 2019
30 Jun 2019	3%	0%	$33,793,000	250,000	0		$135.17	Q2 2019
31 Mar 2019	3.2%	-5.2%	$32,595,000	250,000	-400,000	-62%	$130.38	Q1 2019
31 Dec 2018	8%	-1.2%	$80,893,000	650,000	-100,000	-13%	$124.45	Q4 2018
30 Sep 2018	9.8%	-9.8%	$104,340,000	750,000	-750,000	-50%	$139.12	Q3 2018
30 Jun 2018	15%	0%	$153,900,000	1,500,000	0		$102.60	Q2 2018
31 Mar 2018	15%	0%	$145,500,000	1,500,000	0		$97.00	Q1 2018
31 Dec 2017	16%	0%	$131,760,000	1,500,000	0		$87.84	Q4 2017
30 Sep 2017	16%	+1.1%	$119,385,000	1,500,000	+100,000	+7.1%	$79.59	Q3 2017
30 Jun 2017	16%	+3.1%	$122,080,000	1,400,000	+275,000	+24%	$87.20	Q2 2017
31 Mar 2017	12%	-1.3%	$100,114,000	1,125,000	-125,000	-10%	$88.99	Q1 2017
31 Dec 2016	12%	-1.6%	$92,525,000	1,250,000	-170,000	-12%	$74.02	Q4 2016
30 Sep 2016	14%	+0.69%	$107,395,000	1,420,000	+70,000	+5.2%	$75.63	Q3 2016
30 Jun 2016	13%	0%	$103,964,000	1,350,000	0		$77.01	Q2 2016
31 Mar 2016	13%	+1.4%	$105,368,000	1,350,000	+150,000	+12%	$78.05	Q1 2016
31 Dec 2015	11%	+1.8%	$81,156,000	1,200,000	+200,000	+20%	$67.63	Q4 2015
30 Sep 2015	8.2%	+8.2%	$77,360,000	1,000,000	+1,000,000	NEW	$77.36	Q3 2015
30 Sep 2014		-5.7%	$0	0	-1,087,996	-100%	$497.54	Q3 2014
30 Jun 2014	5.7%	+5.7%	$61,341,000	1,087,996	+1,087,996	NEW	$56.38	Q2 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.